Sero-prevalence of hepatitis B virus and associated factors among pregnant women attending antenatal care in Bosaso general hospital, Puntland, Somalia 2023: A cross-sectional study design

  • Mohyadin Abdullahi Ahmed Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia https://orcid.org/0009-0003-5946-8089
  • Ahmed Mohammed Ibrahim Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia
  • Ramadan Budul Yusuf Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia
  • Beder Jama Yusuf Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia
  • Abdirahman Muhumed Mahamud Department of medical laboratory, Jigjiga health science college, Jigjiga, Ethiopia
  • Fatima Said Duale Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia
  • Mustafe Abdi Ali Department of Statistics, institute Natural and Computational Science, Jigjiga University, Jigjiga, Ethiopia
  • Mustafa Mohamud Farah Department of Statistics, institute Natural and Computational Science, Jigjiga University, Jigjiga, Ethiopia

Abstract

Background: Hepatitis is an inflammation of the liver caused by a variety of infectious and non-infectious agents, leading to a range of health problems. Hepatitis B virus (HBV) can cause    both acute and chronic liver disease, and the most common virus that can be transmitted from mother to child and other modes of transmission are contact with blood or other body fluids during sexual intercourse, unsafe injections, or exposure to sharp instruments.


Objective: To determine the seroprevalence and associated factors of HBV infection among pregnant women attending the Antenatal Clinic at Bosaso General Hospital, Puntland, Somalia, in 2023.


Methods: A cross-sectional study was conducted among 302 pregnant women who underwent routine ANC at Bosaso General hospital from March 15 to May 15. Study participants were interviewed using a structured questionnaire. A systematic random sampling technique was used to identify participants. Data entry, editing, and cleanup of the collected data were performed by the principal investigator using EPI data, and data analysis was performed using SPSS software version 20 to examine the association between each independent variable and the outcome variable. Bivariate and multivariate logistic regression analyses were performed to determine associations.


Result: A total of 302 respondents participated in the study, with a response rate of 96.8%. The overall prevalence of hepatitis B infection among pregnant women was 6.6% (95% CI = 4.0–9.8). Having a history of dental procedures (AOR = 5.52, 95% CI = 1.190–25.68), a history of blood transfusion (AOR = 5.02, 95% CI = 1.088–23.19), a history surgical procedure (AOR = 4.7, 95% CI = 1.014–21.76), or having a family history of HBV infection (AOR = 10.07, 95% CI = (1.27–79.63) were significant predictors of HBV infection among pregnant women.


Conclusion: The seroprevalence of HBV was intermediate (2–8%) in the study area according to WHO classification. A history of dental procedures, blood transfusion, surgical procedures, and a family history of hepatitis B virus infection were significantly associated with HBV infection.


Keywords: Sero-prevalence; Bosaso; hepatitis B virus; pregnant women.

Keywords: Sero-prevalence, Bosaso, hepatitis B virus, pregnant women

Downloads

Download data is not yet available.

Author Biographies

Mohyadin Abdullahi Ahmed, Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Ahmed Mohammed Ibrahim, Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Ramadan Budul Yusuf, Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Beder Jama Yusuf, Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Abdirahman Muhumed Mahamud, Department of medical laboratory, Jigjiga health science college, Jigjiga, Ethiopia

Department of medical laboratory, Jigjiga health science college, Jigjiga, Ethiopia

Fatima Said Duale, Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Department of Public Health, College of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia

Mustafe Abdi Ali, Department of Statistics, institute Natural and Computational Science, Jigjiga University, Jigjiga, Ethiopia

Department of Statistics, institute Natural and Computational Science, Jigjiga University, Jigjiga, Ethiopia

Mustafa Mohamud Farah, Department of Statistics, institute Natural and Computational Science, Jigjiga University, Jigjiga, Ethiopia

Department of Statistics, institute Natural and Computational Science, Jigjiga University, Jigjiga, Ethiopia

References

1. organization Wh. Hepatitis 2023 [Available from: https://www.who.int/health-topics/hepatitis#tab=tab_1.
2. foundation kg. hepatitis B anual 2016 [Available from: https://www.hepatitisbannual.org/currentissue.asp?sabs=n.
3. Tiruye G, Shiferaw K, Tadesse F. Seroprevalence of hepatitis B virus infection and associated factors among pregnant women attended antenatal care services in Harar City, Eastern Ethiopia. Journal of Women's Health Care. 2018;7(3):3-10. https://doi.org/10.4172/2167-0420.1000436
4. Mulligan MJ, Stiehm ER. Neonatal hepatitis B infection: clinical and immunologic considerations. Journal of Perinatology: Official Journal of the California Perinatal Association. 1994;14(1):2-9.
5. Sirilert S, Tongsong T. Hepatitis B Virus Infection in Pregnancy: Immunological Response, Natural Course and Pregnancy Outcomes. Journal of clinical medicine. 2021;10(13). https://doi.org/10.3390/jcm10132926 PMid:34210105 PMCid:PMC8267880
6. Organization WH. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016-2021: actions for impact. 2021.
7. Sonderup MW, Spearman CW. Global disparities in hepatitis B elimination-a focus on Africa. Viruses. 2022;14(1):82. https://doi.org/10.3390/v14010082 PMid:35062286 PMCid:PMC8777803
8. Organization WH. Global hepatitis report 2017: World Health Organization; 2017.
9. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. Journal of hepatology. 2003;39:64-9. https://doi.org/10.1016/S0168-8278(03)00141-7 PMid:14708680
10. de Villiers MJ, Nayagam S, Hallett TB. The impact of the timely birth dose vaccine on the global elimination of hepatitis B. Nature communications. 2021;12(1):6223. https://doi.org/10.1038/s41467-021-26475-6 PMid:34711822 PMCid:PMC8553835
11. Hassan-Kadle MA. The diagnostic challenges, possible etiologies and lack of researches of hepatocellular carcinoma in Somalia. Open Journal of Gastroenterology. 2017;7(03):115. https://doi.org/10.4236/ojgas.2017.73013
12. Roble AK, Roba KT, Mengistie B, Abdurke Kure M. Seroprevalence of hepatitis B virus and associated factors among pregnant women attending antenatal care in public health facilities in Jigjiga Town, Eastern Ethiopia. International Journal of Women's Health. 2021:1299-310. https://doi.org/10.2147/IJWH.S276526 PMid:33447090 PMCid:PMC7801816
13. Mekonnen R, Admasu D, Belete M. Sero-Prevalence of Hepatitis B Virus and associated factors among pregnant mothers attending antenatal care in Public Health Facilities, Dire Dawa. J Med Microb Diagn. 2018;7(281):2161-0703.1000281. https://doi.org/10.4172/2161-0703.1000281
14. Kassaw B, Abera N, Legesse T, Workineh A, Ambaw G. Sero-prevalence and associated factors of hepatitis B virus among pregnant women in Hawassa city public hospitals, Southern Ethiopia: Cross-sectional study design. SAGE Open Medicine. 2022;10:20503121221140778. https://doi.org/10.1177/20503121221140778 PMid:36505974 PMCid:PMC9730001
15. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. International journal of medical sciences. 2005;2(1):50-7. https://doi.org/10.7150/ijms.2.50 PMid:15968340 PMCid:PMC1142225
16. Desalegn Z, Wassie L, Beyene HB, Mihret A, Ebstie YA. Hepatitis B and human immunodeficiency virus co-infection among pregnant women in resource-limited high endemic setting, Addis Ababa, Ethiopia: implications for prevention and control measures. European journal of medical research. 2016;21(1):1-7. https://doi.org/10.1186/s40001-016-0211-3 PMid:27075475 PMCid:PMC4831185
17. Argaw B, Mihret A, Aseffa A, Tarekegne A, Hussen S, Wachamo D, et al. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia. BMC infectious diseases. 2020;20:1-7. https://doi.org/10.1186/s12879-020-05229-7 PMid:32698884 PMCid:PMC7374845
18. Saidu A, Salihu Y, Umar A, Muhammad B, Abdullahi I. Seroprevalence of hepatitis B surface antigen among pregnant women attending ante-natal clinics in Sokoto metropolis. IOSR J Nurs Health Sci. 2015;4(4):46-50.
19. Abongwa LE, Kenneth P. Assessing prevalence and risk factors of hepatitis B surface antigen amongst pregnant women attending antenatal clinic in the Northwest Region of Cameroon. European Journal of Research in Medical Sciences. 2016;4(1).
20. Tadiwos MB, Kanno GG, Areba AS, Kabthymer RH, Abate ZG, Aregu MB. Sero-prevalence of hepatitis B virus infection and associated factors among pregnant women attending antenatal care services in Gedeo Zone, Southern Ethiopia. Journal of Primary Care & Community Health. 2021;12:2150132721993628. https://doi.org/10.1177/2150132721993628 PMid:33565356 PMCid:PMC7878950
21. Amsalu A, Ferede G, Eshetie S, Tadewos A, Assegu D. Prevalence, infectivity, and associated risk factors of hepatitis B virus among pregnant women in Yirgalem Hospital, Ethiopia: implication of screening to control mother-to-child transmission. Journal of pregnancy. 2018;2018. https://doi.org/10.1155/2018/8435910 PMid:30174956 PMCid:PMC6098924
22. Lao TT, Sahota DS, Law L-W, Cheng YK, Leung T-Y. Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China. Bulletin of the World Health Organization. 2014;92:782-9. https://doi.org/10.2471/BLT.13.133413 PMid:25378739 PMCid:PMC4221762
23. Murad EA, Babiker SM, Gasim GI, Rayis DA, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana'a, Yemen. BMC pregnancy and childbirth. 2013;13(1):1-5. https://doi.org/10.1186/1471-2393-13-127 PMid:23758990 PMCid:PMC3684507
24. Mbaawuaga EM, Iroegbu CU, Ike AC, Jombo GTA. Studies on prevalence, co-infection and associated risk factors of hepatitis B virus (HBV) and Human immunodeficiency virus (HIV) in Benue State, Nigeria. Sci J Public Health. 2014;2(6):569-76.
25. Bayo P, Ochola E, Oleo C, Mwaka AD. High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda. BMJ open. 2014;4(11):e005889. https://doi.org/10.1136/bmjopen-2014-005889 PMid:25387757 PMCid:PMC4244481
26. Mohammed AA. Prevalence and risk factors for hepatitis B infection among pregnant women attending antenatal clinics in Garissa district: Laboratory Management and Epidemiology, JKUAT; 2016.
27. Dahie HA, Heyle AA. Prevalence of Hepatitis B and Its Associated Factors Among Pregnant Women in Mogadishu, Somalia. Archives of Business Research. 2017;5(11). https://doi.org/10.14738/abr.511.3876
28. Euler GL, Wooten KG, Baughman AL, Williams WW. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics. 2003;111(Supplement_1):1192-7. https://doi.org/10.1542/peds.111.S1.1192 PMid:12728137
29. Souza MT, Pinho TLRd, Santos MDC, Santos Ad, Monteiro VL, Fonsêca LMB, et al. Prevalence of hepatitis B among pregnant women assisted at the public maternity hospitals of São Luís, Maranhão, Brazil. Brazilian Journal of Infectious Diseases. 2012;16:517-20. https://doi.org/10.1016/j.bjid.2012.07.008 PMid:23168305
30. MacLean B, Hess RF, Bonvillain E, Kamate J, Dao D, Cosimano A, et al. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali. South African Medical Journal. 2012;102(1).
31. Alrowaily MA, Abolfotouh MA, Ferwanah MS. Hepatitis B virus sero-prevalence among pregnant females in Saudi Arabia. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association. 2008;14(2):70. https://doi.org/10.4103/1319-3767.39621 PMid:19568503 PMCid:PMC2702893
32. Choisy M, Keomalaphet S, Xaydalasouk K, Quet F, Latthaphasavang V, Buisson Y. Prevalence of hepatitis B virus infection among pregnant women attending antenatal clinics in Vientiane, Laos, 2008-2014. Hepatitis Research and Treatment. 2017;2017. https://doi.org/10.1155/2017/1284273 PMid:28465839 PMCid:PMC5390595
33. Gedefaw G, Waltengus F, Akililu A, Gelaye K. Risk factors associated with hepatitis B virus infection among pregnant women attending antenatal clinic at Felegehiwot referral hospital, Northwest Ethiopia, 2018: an institution based cross sectional study. BMC research notes. 2019;12:1-7. https://doi.org/10.1186/s13104-019-4561-0 PMid:31416477 PMCid:PMC6694615
34. Negero A, Sisay Z, Medhin G. Prevalence of Hepatitis B surface antigen (HBsAg) among visitors of Shashemene General Hospital voluntary counseling and testing center. BMC research notes. 2011;4(1):1-5. https://doi.org/10.1186/1756-0500-4-35 PMid:21303563 PMCid:PMC3045955
35. Bialfew Y, Hailu G, Samuel T. Prevalence and associated factors of hepatitis B virus infection among blood donors in Debre Markos blood Bank Centre, Northwest Ethiopia, 2018. Epidemiology (Sunnyvale). 2018;8(363):2161-1165.1000363. https://doi.org/10.4172/2161-1165.1000363
36. Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC infectious diseases. 2014;14:1-7. https://doi.org/10.1186/1471-2334-14-118 PMid:24580859 PMCid:PMC3942511
37. Tadesse M, Tafesse G, Hajare ST, Chauhan NM. Assessment of prevalence of Hepatitis B virus and its associated factors among pregnant women from Wolaita Sodo, Ethiopia. Journal of Clinical Virology Plus. 2022;2(2):100069. https://doi.org/10.1016/j.jcvp.2022.100069
38. Abuelgasim MH, Baraka MBK. Prevalence of hepatitis B infection among pregnant women at Khartoum Teaching Hospital, Sudan. J US-China Med Sci. 2015;12(2):58-63. https://doi.org/10.17265/1548-6648/2015.02.003
39. Bani I, Mahfouz MS. Prevalence and risk Women in Jazan. Prevalence. 2012;2(7).
40. Nyamusi MM, M'Imunya JM, Muvunyi CM, Habtu M. Factors associated with Hepatitis B surface antigen seropositivity among pregnant women in Kigali, Rwanda: a cross sectional study. 2017.
41. Demeke G, Ayalneh GM, Shiferaw AA, Toru M, Dilnessa T. Sero-prevalence and associated factors of hepatitis B virus among pregnant women at north West Ethiopia: an institution-based cross-sectional study. International Journal of General Medicine. 2021:2799-805. https://doi.org/10.2147/IJGM.S320711 PMid:34194239 PMCid:PMC8238533
Crossmark
Statistics
38 Views | 8 Downloads
How to Cite
1.
Ahmed MA, Ibrahim AM, Yusuf R, Yusuf BJ, Mahamud AM, Duale FS, Ali MA, Farah MM. Sero-prevalence of hepatitis B virus and associated factors among pregnant women attending antenatal care in Bosaso general hospital, Puntland, Somalia 2023: A cross-sectional study design. JDDT [Internet]. 15May2024 [cited 17May2024];14(5):78-5. Available from: https://jddtonline.info/index.php/jddt/article/view/6564